{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:56:52Z","timestamp":1789397812453,"version":"build-2803163510"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008562","name":"University of Texas at Austin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/QUI-OUT\/3143\/2021"],"award-info":[{"award-number":["PTDC\/QUI-OUT\/3143\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UTAP-EXPL\/NTec\/0038\/2017"],"award-info":[{"award-number":["UTAP-EXPL\/NTec\/0038\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ijpharm.2022.122575","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T01:46:04Z","timestamp":1672623964000},"page":"122575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations"],"prefix":"10.1016","volume":"632","author":[{"given":"Stefania","family":"Scialla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud S.","family":"Hanafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Genicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milene","family":"Costa Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Oliveira-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Baltazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ba\u00f1obre-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2022.122575_b0005","doi-asserted-by":"crossref","DOI":"10.1098\/rsta.2018.0216","article-title":"Effect of Interparticle Interaction on Magnetic Hyperthermia: Homogeneous Spatial Distribution of the Particles","author":"Abu-Bakr","year":"2019","journal-title":"Philos. Trans. R. Soc. A Math. Phys. Eng. Sci."},{"key":"10.1016\/j.ijpharm.2022.122575_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2020.12.012","article-title":"ADAM 8 as a Novel Target for Doxorubicin Delivery to TNBC Cells Using Magnetic Thermosensitive Liposomes","author":"Alawak","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2022.122575_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and Zeta Potential - What They Are and What They Are Not?","author":"Bhattacharjee","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2022.122575_b0020","doi-asserted-by":"crossref","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-Negative Breast Cancer: Challenges and Opportunities of a Heterogeneous Disease","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijpharm.2022.122575_b0025","doi-asserted-by":"crossref","unstructured":"Binns, C., 2014. Tutorial Section on Nanomagnetism. In Frontiers of Nanoscience; 2014. https:\/\/doi.org\/10.1016\/B978-0-08-098353-0.00001-4.","DOI":"10.1016\/B978-0-08-098353-0.00001-4"},{"key":"10.1016\/j.ijpharm.2022.122575_b0030","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date","author":"Bobo","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2022.122575_b0035","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz173","article-title":"Early Breast Cancer: ESMO Clinical Practice Guidelines for Diagnosis. Treatment and Follow-Up","author":"Cardoso","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ijpharm.2022.122575_b0040","article-title":"PARP Inhibitors in Cancer Diagnosis and Therapy","author":"Chan","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.ijpharm.2022.122575_b0045","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.3390\/ijms231710068","article-title":"Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy","volume":"23","author":"Chaudhuri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpharm.2022.122575_b0050","article-title":"Advances in Cancer Theranostics Using Organic-Inorganic Hybrid Nanotechnology","author":"Chen","year":"2021","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.ijpharm.2022.122575_b0055","doi-asserted-by":"crossref","DOI":"10.1021\/acs.langmuir.5b03559","article-title":"Effect of Nanoclustering and Dipolar Interactions in Heat Generation for Magnetic Hyperthermia","author":"Coral","year":"2016","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2022.122575_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems","author":"Danaei","year":"2018","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ijpharm.2022.122575_b0065","doi-asserted-by":"crossref","unstructured":"de la Fuente, M., Langer, R., Alonso, M. J., 2014. Nanotechnology Approaches for Cancer Immunotherapy and Immunomodulation; 2014. https:\/\/doi.org\/10.1007\/978-3-319-08084-0_8.","DOI":"10.1007\/978-3-319-08084-0_8"},{"key":"10.1016\/j.ijpharm.2022.122575_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040819","article-title":"Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes","author":"Diana","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ijpharm.2022.122575_b0075","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2147\/IJN.S289443","article-title":"Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives","volume":"16","author":"Edis","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpharm.2022.122575_b0080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.addr.2021.03.004","article-title":"Oral Lipid Nanomedicines: Current Status and Future Perspectives in Cancer Treatment","volume":"173","author":"El Moukhtari","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2022.122575_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms16048070","article-title":"Iron Oxide Nanoparticles for Magnetically-Guided and Magnetically-Responsive Drug Delivery","author":"Estelrich","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpharm.2022.122575_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2012.01.034","article-title":"Efficient Intracellular Drug-Targeting of Macrophages Using Stealth Liposomes Directed to the Hemoglobin Scavenger Receptor CD163","author":"Etzerodt","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2022.122575_b0095","doi-asserted-by":"crossref","DOI":"10.1021\/ja067457e","article-title":"Size-Sorted Anionic Iron Oxide Nanomagnets as Colloidal Mediators for Magnetic Hyperthermia","author":"Fortin","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2022.122575_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/S0378-5173(98)00092-1","article-title":"Effect of Light and Temperature on Zeta Potential and Physical Stability in Solid Lipid Nanoparticle (SLN\u00ae) Dispersions","author":"Freitas","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2022.122575_b0105","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.6b01148","article-title":"Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes","author":"Garg","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2022.122575_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2016.05.119","article-title":"Solid Lipid Nanoparticles as Attractive Drug Vehicles: Composition, Properties and Therapeutic Strategies","author":"Geszke-Moritz","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijpharm.2022.122575_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073607","article-title":"IMD-0354 Targets Breast Cancer Stem Cells: A Novel Approach for an Adjuvant to Chemotherapy to Prevent Multidrug Resistance in a Murine Model","author":"Gomez-Cabrero","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2022.122575_b0120","doi-asserted-by":"crossref","DOI":"10.1007\/s11060-018-03005-x","article-title":"Combined Intracavitary Thermotherapy with Iron Oxide Nanoparticles and Radiotherapy as Local Treatment Modality in Recurrent Glioblastoma Patients","author":"Grauer","year":"2019","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ijpharm.2022.122575_b0125","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.6b08663","article-title":"Sub-Micrometer Magnetic Nanocomposites: Insights into the Effect of Magnetic Nanoparticles Interactions on the Optimization of SAR and MRI Performance","author":"Grillo","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijpharm.2022.122575_b0130","doi-asserted-by":"crossref","DOI":"10.2217\/nnm-2018-0436","article-title":"Nutlin-Loaded Magnetic Solid Lipid Nanoparticles for Targeted Glioblastoma Treatment","author":"Grillone","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpharm.2022.122575_b0135","article-title":"Dual Complementary Liposomes Inhibit Triple-Negative Breast Tumor Progression and Metastasis","author":"Guo","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijpharm.2022.122575_b0140","doi-asserted-by":"crossref","DOI":"10.1159\/000455999","article-title":"Germline Mutations in Triple-Negative Breast Cancer","author":"Hahnen","year":"2017","journal-title":"Breast Care."},{"key":"10.1016\/j.ijpharm.2022.122575_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2011.11.013","article-title":"Targeted Delivery of Oligonucleotides into Tumor-Associated Macrophages for Cancer Immunotherapy","author":"Huang","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2022.122575_b0150","doi-asserted-by":"crossref","DOI":"10.1172\/JCI72931","article-title":"Cardiotoxicity of Doxorubicin Is Mediated through Mitochondrial Iron Accumulation","author":"Ichikawa","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijpharm.2022.122575_b0155","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S255636","article-title":"Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant","author":"Iqbal","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpharm.2022.122575_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2013.02.035","article-title":"Synthesis of Oleic Acid Functionalized Fe3O4 Magnetic Nanoparticles and Studying Their Interaction with Tumor Cells for Potential Hyperthermia Applications","author":"Jadhav","year":"2013","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2022.122575_b0165","doi-asserted-by":"crossref","DOI":"10.1177\/1536012116689499","article-title":"Targeted Imaging of Tumor-Associated Macrophages by Cyanine 7-Labeled Mannose in Xenograft Tumors","author":"Jiang","year":"2017","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.ijpharm.2022.122575_b0170","doi-asserted-by":"crossref","DOI":"10.1080\/1061186X.2017.1380655","article-title":"Advances in Nano-Delivery Systems for Doxorubicin: An Updated Insight","author":"Kanwal","year":"2018","journal-title":"J. Drug Target."},{"issue":"9","key":"10.1016\/j.ijpharm.2022.122575_b0175","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/pharmaceutics14091886","article-title":"Review on the Scale-Up Methods for the Preparation of Solid Lipid Nanoparticles","volume":"14","author":"Khairnar","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2022.122575_b0180","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.8b01065","article-title":"Targeted Lipid Nanoemulsions Encapsulating Epigenetic Drugs Exhibit Selective Cytotoxicity on CDH1-\/FOXM1+ Triple Negative Breast Cancer Cells","author":"Kim","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2022.122575_b0185","doi-asserted-by":"crossref","DOI":"10.1166\/jnn.2008.15348","article-title":"Superparamagnetism and Other Magnetic Features in Granular Materials: A Review on Ideal and Real Systems","author":"Knobel","year":"2008","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2022.122575_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/0378-5173(83)90064-9","article-title":"Mechanisms of Solute Release from Porous Hydrophilic Polymers","author":"Korsmeyer","year":"1983","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2022.122575_b0195","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevB.89.014403","article-title":"Role of Dipolar Interaction in Magnetic Hyperthermia","author":"Landi","year":"2014","journal-title":"Phys. Rev. B - Condens. Matter Mater. Phys."},{"key":"10.1016\/j.ijpharm.2022.122575_b0200","article-title":"Designed Synthesis of Uniformly Sized Iron Oxide Nanoparticles for Efficient Magnetic Resonance Imaging Contrast Agents","author":"Lee","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijpharm.2022.122575_b0205","doi-asserted-by":"crossref","DOI":"10.1021\/acs.chemrev.5b00112","article-title":"Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy","author":"Lee","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijpharm.2022.122575_b0210","article-title":"Targeted Imaging of CD206 Expressing Tumor-Associated M2-like Macrophages Using Mannose-Conjugated Antibiofouling Magnetic Iron Oxide Nanoparticles","author":"Li","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ijpharm.2022.122575_b0215","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to Neoadjuvant Therapy and Long-Term Survival in Patients with Triple-Negative Breast Cancer","author":"Liedtke","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijpharm.2022.122575_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2012.07.022","article-title":"PET Imaging of Tumor Associated Macrophages Using Mannose Coated 64Cu Liposomes","author":"Locke","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2022.122575_b0225","doi-asserted-by":"crossref","DOI":"10.21873\/anticanres.14619","article-title":"Potential for Treatment of Glioblastoma: New Aspects of Superparamagnetic Iron Oxide Nanoparticles","author":"Marekova","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ijpharm.2022.122575_b0230","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2003-03-0869","article-title":"Hfe Deficiency Increases Susceptibility to Cardiotoxicity and Exacerbates Changes in Iron Metabolism Induced by Doxorubicin","author":"Miranda","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ijpharm.2022.122575_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040191","article-title":"Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems","author":"Mishra","year":"2018","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ijpharm.2022.122575_b0240","article-title":"Magnetic Hybrid Wax Nanocomposites as Externally Controlled Theranostic Vehicles: High MRI Enhancement and Synergistic Magnetically Assisted Thermo\/Chemo Therapy","author":"Moura","year":"2020","journal-title":"Chem. \u2013 A Eur. J."},{"key":"10.1016\/j.ijpharm.2022.122575_b0245","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-11-2994","article-title":"Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective in Vivo Imaging of Tumor-Associated Macrophages","author":"Movahedi","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2022.122575_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2013.06.013","article-title":"The Effective Encapsulation of a Hydrophobic Lipid-Insoluble Drug in Solid Lipid Nanoparticles Using a Modified Double Emulsion Solvent Evaporation Method","author":"Nabi-Meibodi","year":"2013","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2022.122575_b0255","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-009-0667-x","article-title":"Targeting Tumor-Associated Macrophages in an Experimental Glioma Model with a Recombinant Immunotoxin to Folate Receptor \u03b2","author":"Nagai","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ijpharm.2022.122575_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/cells8090957","article-title":"Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge","author":"Nedeljkovi\u0107","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ijpharm.2022.122575_b0265","article-title":"Magnetic Properties of Magnetic Nanoparticles for Efficient Hyperthermia","author":"Obaidat","year":"2014","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ijpharm.2022.122575_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2018.11.122","article-title":"Nanosoldiers: A Promising Strategy to Combat Triple Negative Breast Cancer","author":"Pawar","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpharm.2022.122575_b0275","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.115.158956","article-title":"PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles","author":"P\u00e9rez-Medina","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ijpharm.2022.122575_b0280","doi-asserted-by":"crossref","unstructured":"SS Pindiprolu, S. K.; Krishnamurthy, P. T.; Ghanta, V. R.; Chintamaneni, P. K. Phenyl Boronic Acid-Modified Lipid Nanocarriers of Niclosamide for Targeting Triple-Negative Breast Cancer. Nanomedicine 2020, 15 (16), 1551\u20131565.","DOI":"10.2217\/nnm-2020-0003"},{"key":"10.1016\/j.ijpharm.2022.122575_b0285","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.112.111781","article-title":"SPECT Imaging of Joint Inflammation with Nanobodies Targeting the Macrophage Mannose Receptor in a Mouse Model for Rheumatoid Arthritis","author":"Put","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ijpharm.2022.122575_b0290","article-title":"Toxic Effects and Molecular Mechanism of Doxorubicin on Different Organs\u2013an Update","author":"Renu","year":"2021","journal-title":"Toxin Rev."},{"key":"10.1016\/j.ijpharm.2022.122575_b0295","doi-asserted-by":"crossref","DOI":"10.1097\/01.rli.0000184756.66360.d3","article-title":"Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths","author":"Rohrer","year":"2005","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.ijpharm.2022.122575_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/S0304-8853(02)00706-0","article-title":"Heating Magnetic Fluid with Alternating Magnetic Field","author":"Rosensweig","year":"2002","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.ijpharm.2022.122575_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2017.10.007","article-title":"Triple Negative Breast Cancer: Key Role of Tumor-Associated Macrophages in Regulating the Activity of Anti-PD-1\/PD-L1 Agents","author":"Santoni","year":"2018","journal-title":"Biochim. Biophys. Acta \u2013 Rev. Cancer."},{"key":"10.1016\/j.ijpharm.2022.122575_b0310","unstructured":"Shah, R., Eldridge, D., Palombo, E., Harding, I., 2014. Optimisation and Stability Assessment of Solid Lipid Nanoparticles Using Particle Size and Zeta Potential. J. Phys. Sci. 2014."},{"key":"10.1016\/j.ijpharm.2022.122575_b0315","doi-asserted-by":"crossref","unstructured":"Siddhartha, V. T., Pindiprolu, S. K. S. S., Chintamaneni, P. K., Tummala, S., Nandha Kumar, S., 2018. RAGE Receptor Targeted Bioconjuguate Lipid Nanoparticles of Diallyl Disulfide for Improved Apoptotic Activity in Triple Negative Breast Cancer: In Vitro Studies. Artif. cells, Nanomedicine, Biotechnol. 2018, 46 (2), 387\u2013397.","DOI":"10.1080\/21691401.2017.1313267"},{"key":"10.1016\/j.ijpharm.2022.122575_b0320","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2009.22.4725","article-title":"Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer","author":"Silver","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijpharm.2022.122575_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2020.06.025","article-title":"Cancer Therapy with Iron Oxide Nanoparticles: Agents of Thermal and Immune Therapies","author":"Soetaert","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2022.122575_b0330","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwz201","article-title":"Ferrimagnetic MPEG-b-PHEP Copolymer Micelles Loaded with Iron Oxide Nanocubes and Emodin for Enhanced Magnetic Hyperthermia-Chemotherapy","author":"Song","year":"2020","journal-title":"Natl. Sci. Rev."},{"issue":"4","key":"10.1016\/j.ijpharm.2022.122575_b0335","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3109\/10717544.2015.1092183","article-title":"Lipid-Based Nanocarriers for Breast Cancer Treatment-Comprehensive Review","volume":"23","author":"Talluri","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2022.122575_b0340","doi-asserted-by":"crossref","DOI":"10.1039\/C8NR05520C","article-title":"Stimuli-Responsive Lipid-Based Magnetic Nanovectors Increase Apoptosis in Glioblastoma Cells through Synergic Intracellular Hyperthermia and Chemotherapy","author":"Tapeinos","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijpharm.2022.122575_b0345","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1443-1","article-title":"Recent Advances in Nanotheranostics for Triple Negative Breast Cancer Treatment","author":"Thakur","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijpharm.2022.122575_b0350","article-title":"Targeting Monocytes and Macrophages by Means of SPECT and PET","author":"Van De Wiele","year":"2014","journal-title":"Quart. J. Nucl. Med. Mol. Imaging."},{"key":"10.1016\/j.ijpharm.2022.122575_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2017.06.023","article-title":"Mechanisms of Resistance of Chemotherapy in Early-Stage Triple Negative Breast Cancer (TNBC)","author":"Wein","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.ijpharm.2022.122575_b0360","unstructured":"WHO. Preventing cancer. https:\/\/www.who.int\/activities\/preventing-cancer."},{"key":"10.1016\/j.ijpharm.2022.122575_b0365","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S207837","article-title":"Nanosized Functional MiRNA Liposomes and Application in the Treatment of TNBC by Silencing Slug Gene","author":"Yan","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpharm.2022.122575_b0370","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-Negative Breast Cancer Molecular Subtyping and Treatment Progress","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ijpharm.2022.122575_b0375","doi-asserted-by":"crossref","DOI":"10.1111\/cas.14181","article-title":"Targeted Exosome-Encapsulated Erastin Induced Ferroptosis in Triple Negative Breast Cancer Cells","author":"Yu","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ijpharm.2022.122575_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2016.08.061","article-title":"Anti-Tumor Efficiency of Paclitaxel and DNA When Co-Delivered by PH Responsive Ligand Modified Nanocarriers for Breast Cancer Treatment","author":"Yu","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpharm.2022.122575_b0385","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: An Add-in Program for Modeling and Comparison of Drug Dissolution Profiles","author":"Zhang","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2022.122575_b0390","article-title":"Dual-Targeted Hybrid Nanoparticles of Synergistic Drugs for Treating Lung Metastases of Triple Negative Breast Cancer in Mice","author":"Zhang","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijpharm.2022.122575_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118595","article-title":"Construction and in Vitro and in Vivo Evaluation of Folic Acid-Modified Nanostructured Lipid Carriers Loaded with Paclitaxel and Chlorin E6","author":"Zhang","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2022.122575_b0400","doi-asserted-by":"crossref","unstructured":"Zhao, N.; C Woodle, M.; Mixson, A. J. Advances in Delivery Systems for Doxorubicin. J. Nanomed. Nanotechnol. 2018. https:\/\/doi.org\/10.4172\/2157-7439.1000519.","DOI":"10.4172\/2157-7439.1000519"},{"key":"10.1016\/j.ijpharm.2022.122575_b0405","article-title":"Improving Breast Cancer Therapy Using Doxorubicin Loaded Solid Lipid Nanoparticles: Synthesis of a Novel Arginine-Glycine-Aspartic Tripeptide Conjugated, PH Sensitive Lipid and Evaluation of the Nanomedicine in Vitro and in Vivo","author":"Zheng","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpharm.2022.122575_b0410","doi-asserted-by":"crossref","DOI":"10.1021\/mp400216r","article-title":"Targeting of Tumor-Associated Macrophages Made Possible by PEG-Sheddable. Mannose-Modified Nanoparticles","author":"Zhu","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2022.122575_b0415","doi-asserted-by":"crossref","unstructured":"Zhu, S.; Wonganan, P.; Lansakara-P., D. S. P.; O\u2019Mary, H. L.; Li, Y.; Cui, Z. The Effect of the Acid-Sensitivity of 4-(N)-Stearoyl Gemcitabine-Loaded Micelles on Drug Resistance Caused by RRM1 Overexpression. Biomaterials 2013. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.11.053.","DOI":"10.1016\/j.biomaterials.2012.11.053"},{"key":"10.1016\/j.ijpharm.2022.122575_b0420","doi-asserted-by":"crossref","DOI":"10.2217\/nnm-2016-0316","article-title":"Magnetic Nanoparticles for Precision Oncology: Theranostic Magnetic Iron Oxide Nanoparticles for Image-Guided and Targeted Cancer Therapy","author":"Zhu","year":"2017","journal-title":"Nanomedicine"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517322011309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517322011309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T17:32:36Z","timestamp":1736357556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517322011309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":84,"alternative-id":["S0378517322011309"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122575","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122575"}}